secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evolent Health, Inc. (EVH)
CIK:        0001628908
Form:       8-K
Filed at:   2025-08-19T23:59:59+00:00
Accession:  0001193125-25-183075
Event type: debt
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Evolent prices upsized $145M convertible notes at 4.50%; uses proceeds to repurchase 2025 notes and common stock.
--------------------------------------------------------------------------------

- Priced $145M (upsized from $140M) of 4.50% convertible senior notes due 2031; initial purchasers have 30-day option for additional $21.75M.
- Conversion price ~$13.53/share, representing ~50% premium over $9.02 closing price on Aug 18, 2025.
- Net proceeds estimated at $140.2M ($161.2M if option fully exercised), after fees and expenses.
- Approximately $100.2M plus available liquidity to repurchase ~$167.4M of existing 1.50% 2025 notes; ~$40M to repurchase 4.43M common shares at $9.02/sh.
- CFO states transaction avoids over $9M annual interest vs. credit facilities and extends next debt maturity to 2029.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1628908/000119312525183075/0001193125-25-183075-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1628908/000119312525183075/d30469d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-183075

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer